Moderna
MRNA
#290
Rank
NZ$144.23 B
Marketcap
NZ$356.46
Share price
-2.17%
Change (1 day)
724.34%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$7.67 Billion

According to Moderna 's latest financial reports the company's total liabilities are NZ$7.67 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$6.36 B10.81%
2024-12-31NZ$5.74 B-20.51%
2023-12-31NZ$7.22 B-31.85%
2022-12-31NZ$10.60 B-31.15%
2021-12-31NZ$15.40 B132.77%
2020-12-31NZ$6.61 B975.19%
2019-12-31NZ$0.61 B-4.39%
2018-12-31NZ$0.64 B-0.41%
2017-12-31NZ$0.64 B-22.15%
2016-12-31NZ$0.83 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$211.85 B 2,659.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$145.48 B 1,794.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$160.53 B 1,990.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$10.59 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$80.1 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.02 B 4.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$3.00 B-60.81%๐Ÿ‡บ๐Ÿ‡ธ USA